AbolerIS Pharma Announces €27 Million in Series A Financing led by Caixa Capital Risc to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases

by Caixa Capital Risc

AbolerIS Pharma, a Belgian biopharmaceutical company developing an entirely novel approach to the treatment of chronic autoimmune and inflammatory diseases, today announced a €27.3 million Series A ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

A&G drives forward the development of 12...

by Grupo A&G

Through its A&G Real Estate Sustainable Developments SICC S.A., A&G wi...

Photos Stream